Pharma Focus Asia
KP - Sustainable Packaging Solutions

Piramal to establish first private opium processing company

The Mumbai-based Piramal Healthcare plans to set up a manufacturing unit to process raw opium for pharmaceutical use. It helps domestic pharma companies in locally procuring opium-based products like morphine, codeine and thebaine. Indian opium contains a range of chemical compounds such as morphine, codeine, thebaine, noscapine and papaverine, which have widespread medical and scientific uses. In making cough syrups, Codeine is one of the most sought opium products by the Indian pharmaceutical industry.


The plant will be set up at the company's existing facility at Baddi in Himachal Pradesh.


The estimated cost of setting up the plant is between US$ 14 - 20 million.


This opium processing unit would reduce the dependency on imported codeine. Piramal Healthcare has also entered a technological tie-up with a US-based firm to produce opium-based drugs.

Specifications Table:

  • Company Name
  • Piramal's Opium Processing Unit
  • Location
  • Baddi, Himachal Pradesh, India
  • Construction Type
  • New Construction
  • Date of Start
  • 2009
  • Date of Completion
  • 2010
  • Estimated Investment
  • US$ 14 - 20 million
  • Promoters
  • Piramal Healthcare
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?